2019 - NANETS https://nanets.net/abstracts-archive/2019?format=html Thu, 19 Sep 2019 21:22:20 -0400 en-GB hourly 1 C39 - Operative Resection of Duodenal Carcinoid Tumors: A Single Center Experience https://nanets.net/abstracts-archive/2019/1304-c39-operative-resection-of-duodenal-carcinoid-tumors-a-single-center-experience?format=html C39 - Operative Resection of Duodenal Carcinoid Tumors: A Single Center Experience Shria Kumar; Nadim Mahmud; Bryson Katona; Robert Roses; Gregory Ginsberg; David Metz

Abstract ID: 17

]]> https://nanets.net/abstracts-archive/2019/1304-c39-operative-resection-of-duodenal-carcinoid-tumors-a-single-center-experience?format=html Shria Kumar; Nadim Mahmud; Bryson Katona; Robert Roses; Gregory Ginsberg; David Metz

Abstract ID: 17

]]> terryh@adgcommunications.com (Holly Terry) 2019 Thu, 19 Sep 2019 21:22:20 -0400 B3 - Differential Gene Expression in Metastatic Pancreatic Neuroendocrine Tumors Predicts Novel Therapeutic Agents https://nanets.net/abstracts-archive/2019/1355-b3-differential-gene-expression-in-metastatic-pancreatic-neuroendocrine-tumors-predicts-novel-therapeutic-agents?format=html B3 - Differential Gene Expression in Metastatic Pancreatic Neuroendocrine Tumors Predicts Novel Therapeutic Agents Aaron Scott; Michelle Weitz; Patrick Breheny; Po Hien Ear; Benjamin Darbro; Bart Brown; Terry Braun; Guiying Li; Ume Salma Shaik Amjad; Courtney Kaemmer; Chandra Kumar Maharjan; Dawn Quelle; Andrew Bellizzi; Joseph Dillon; Thomas O’Dorisio; James Howe

Abstract ID: 106

]]> https://nanets.net/abstracts-archive/2019/1355-b3-differential-gene-expression-in-metastatic-pancreatic-neuroendocrine-tumors-predicts-novel-therapeutic-agents?format=html Aaron Scott; Michelle Weitz; Patrick Breheny; Po Hien Ear; Benjamin Darbro; Bart Brown; Terry Braun; Guiying Li; Ume Salma Shaik Amjad; Courtney Kaemmer; Chandra Kumar Maharjan; Dawn Quelle; Andrew Bellizzi; Joseph Dillon; Thomas O’Dorisio; James Howe

Abstract ID: 106

]]> terryh@adgcommunications.com (Holly Terry) 2019 Thu, 19 Sep 2019 17:25:56 -0400 B4 - RABL6A Promotes PNET Angiogenesis and Development in Vivo https://nanets.net/abstracts-archive/2019/1356-b4-rabl6a-promotes-pnet-angiogenesis-and-development-in-vivo?format=html B4 - RABL6A Promotes PNET Angiogenesis and Development in Vivo Chandra Kumar Maharjan; Courtney Kaemmer; Casey Bauchle; Samuel Stephens; David Meyerholz; Dawn Quelle

Abstract ID: 135

]]> https://nanets.net/abstracts-archive/2019/1356-b4-rabl6a-promotes-pnet-angiogenesis-and-development-in-vivo?format=html Chandra Kumar Maharjan; Courtney Kaemmer; Casey Bauchle; Samuel Stephens; David Meyerholz; Dawn Quelle

Abstract ID: 135

]]> terryh@adgcommunications.com (Holly Terry) 2019 Thu, 19 Sep 2019 17:25:56 -0400 B1 - Liquid Biopsy Metabolomic Profiling of Neuroendocrine Cancer Patients https://nanets.net/abstracts-archive/2019/1353-b1-liquid-biopsy-metabolomic-profiling-of-neuroendocrine-cancer-patients?format=html B1 - Liquid Biopsy Metabolomic Profiling of Neuroendocrine Cancer Patients Nicholas Skill; Elliott Campbell; Tanja Milosavljevic; Elise Chouest; Brianne Voros; Eugene Woltering; Mary Maluccio

Abstract ID: 20

]]> https://nanets.net/abstracts-archive/2019/1353-b1-liquid-biopsy-metabolomic-profiling-of-neuroendocrine-cancer-patients?format=html Nicholas Skill; Elliott Campbell; Tanja Milosavljevic; Elise Chouest; Brianne Voros; Eugene Woltering; Mary Maluccio

Abstract ID: 20

]]> terryh@adgcommunications.com (Holly Terry) 2019 Thu, 19 Sep 2019 17:25:55 -0400 B2 - Upregulation of Immune Signaling Pathways Differentiates Metastaticfrom Localized Pancreatic Neuroendocrine Tumors https://nanets.net/abstracts-archive/2019/1354-b2-upregulation-of-immune-signaling-pathways-differentiates-metastaticfrom-localized-pancreatic-neuroendocrine-tumors?format=html B2 - Upregulation of Immune Signaling Pathways Differentiates Metastaticfrom Localized Pancreatic Neuroendocrine Tumors Jessica Limberg; Akanksha Verma; Timothy Ullmann; Maureen Moore; Dessislava Stefanova; Brendan Finnerty; Toni Beninato; Rasa Zarnegar; Olivier Elemento; Thomas Fahey, III; Irene Min

Abstract ID: 37

]]> https://nanets.net/abstracts-archive/2019/1354-b2-upregulation-of-immune-signaling-pathways-differentiates-metastaticfrom-localized-pancreatic-neuroendocrine-tumors?format=html Jessica Limberg; Akanksha Verma; Timothy Ullmann; Maureen Moore; Dessislava Stefanova; Brendan Finnerty; Toni Beninato; Rasa Zarnegar; Olivier Elemento; Thomas Fahey, III; Irene Min

Abstract ID: 37

]]> terryh@adgcommunications.com (Holly Terry) 2019 Thu, 19 Sep 2019 17:25:55 -0400 T5 - 131I MIBG and 90Y DOTATOC in a Dosimetrically Determined Optimal Combination for Personalized Therapy of Selected Patients with Midgut Neuroendocrine Tumors: A First-In-Man Clinical Trial https://nanets.net/abstracts-archive/2019/1350-t5-131i-mibg-and-90y-dotatoc-in-a-dosimetrically-determined-optimal-combination-for-personalized-therapy-of-selected-patients-with-midgut-neuroendocrine-tumors-a-first-in-man-clinical-trial?format=html T5 - 131I MIBG and 90Y DOTATOC in a Dosimetrically Determined Optimal Combination for Personalized Therapy of Selected Patients with Midgut Neuroendocrine Tumors: A First-In-Man Clinical Trial Kellie Bodeker; David Bushnell; Mark Madsen; Yusuf Menda; Kristin Gaimari-Varner; Stephen Graves; Thomas O'Dorisio; Joseph Dillon; Chandrikha Chandrasekharan

Abstract ID: 136

]]> https://nanets.net/abstracts-archive/2019/1350-t5-131i-mibg-and-90y-dotatoc-in-a-dosimetrically-determined-optimal-combination-for-personalized-therapy-of-selected-patients-with-midgut-neuroendocrine-tumors-a-first-in-man-clinical-trial?format=html Kellie Bodeker; David Bushnell; Mark Madsen; Yusuf Menda; Kristin Gaimari-Varner; Stephen Graves; Thomas O'Dorisio; Joseph Dillon; Chandrikha Chandrasekharan

Abstract ID: 136

]]> terryh@adgcommunications.com (Holly Terry) 2019 Thu, 19 Sep 2019 17:22:40 -0400 T6 - A Phase 2 Study Evaluating a Proprietary Amino Acid Based Medical Food (Enterade) in Patients with Quality of Life Limiting Diarrhea Due to Carcinoid Syndrome and Other Neuroendocrine Tumors https://nanets.net/abstracts-archive/2019/1351-t6-a-phase-2-study-evaluating-a-proprietary-amino-acid-based-medical-food-enterade-in-patients-with-quality-of-life-limiting-diarrhea-due-to-carcinoid-syndrome-and-other-neuroendocrine-tumors?format=html T6 - A Phase 2 Study Evaluating a Proprietary Amino Acid Based Medical Food (Enterade) in Patients with Quality of Life Limiting Diarrhea Due to Carcinoid Syndrome and Other Neuroendocrine Tumors Aman Chauhan; Mark Evers; Heidi Weiss; Val Adams; Jill Kolesar; Donald Cohen; Susanne Arnold; Lowell Anthony

Abstract ID: 152

]]> https://nanets.net/abstracts-archive/2019/1351-t6-a-phase-2-study-evaluating-a-proprietary-amino-acid-based-medical-food-enterade-in-patients-with-quality-of-life-limiting-diarrhea-due-to-carcinoid-syndrome-and-other-neuroendocrine-tumors?format=html Aman Chauhan; Mark Evers; Heidi Weiss; Val Adams; Jill Kolesar; Donald Cohen; Susanne Arnold; Lowell Anthony

Abstract ID: 152

]]> terryh@adgcommunications.com (Holly Terry) 2019 Thu, 19 Sep 2019 17:22:40 -0400 T7 - A Pilot Phase 2 Study of S-1 and Temozolomide as Second-Line Treatment in Patients with Advanced or Metastatic Neuroendocrine Carcinoma https://nanets.net/abstracts-archive/2019/1352-t7-a-pilot-phase-2-study-of-s-1-and-temozolomide-as-second-line-treatment-in-patients-with-advanced-or-metastatic-neuroendocrine-carcinoma?format=html T7 - A Pilot Phase 2 Study of S-1 and Temozolomide as Second-Line Treatment in Patients with Advanced or Metastatic Neuroendocrine Carcinoma Xin Wang; Zhirong Qi; Huangying Tan

Abstract ID: 165

]]> https://nanets.net/abstracts-archive/2019/1352-t7-a-pilot-phase-2-study-of-s-1-and-temozolomide-as-second-line-treatment-in-patients-with-advanced-or-metastatic-neuroendocrine-carcinoma?format=html Xin Wang; Zhirong Qi; Huangying Tan

Abstract ID: 165

]]> terryh@adgcommunications.com (Holly Terry) 2019 Thu, 19 Sep 2019 17:22:40 -0400 T3 - Impact of Baseline Liver Tumor Burden, Alkaline Phosphatase (ALP) Elevation,and Target Size Lesion on Therapeutic Effect of 177Lu-DOTATATE Treatment: Analysis of Progression Free Survival, and Safety in NETTER-1 Study https://nanets.net/abstracts-archive/2019/1348-t3-impact-of-baseline-liver-tumor-burden-alkaline-phosphatase-alp-elevation-and-target-size-lesion-on-therapeutic-effect-of-177lu-dotatate-treatment-analysis-of-progression-free-survival-and-safety-in-netter-1-study?format=html T3 - Impact of Baseline Liver Tumor Burden, Alkaline Phosphatase (ALP) Elevation,and Target Size Lesion on Therapeutic Effect of 177Lu-DOTATATE Treatment: Analysis of Progression Free Survival, and Safety in NETTER-1 Study Jonathan Strosberg; Pamela Kunz; Andrew Hendifar; James Yao; David Bushnell; Matthew Kulke; Richard Baum; Caplin Martin; Philippe Ruszniewski; Ebrahim Delpassand; Timothy Hobday; Chris Verslype; Al Benson; Berna Polack; Beilei He; Paola Santoro; Eric Krenning

Abstract ID: 115

]]> https://nanets.net/abstracts-archive/2019/1348-t3-impact-of-baseline-liver-tumor-burden-alkaline-phosphatase-alp-elevation-and-target-size-lesion-on-therapeutic-effect-of-177lu-dotatate-treatment-analysis-of-progression-free-survival-and-safety-in-netter-1-study?format=html Jonathan Strosberg; Pamela Kunz; Andrew Hendifar; James Yao; David Bushnell; Matthew Kulke; Richard Baum; Caplin Martin; Philippe Ruszniewski; Ebrahim Delpassand; Timothy Hobday; Chris Verslype; Al Benson; Berna Polack; Beilei He; Paola Santoro; Eric Krenning

Abstract ID: 115

]]> terryh@adgcommunications.com (Holly Terry) 2019 Thu, 19 Sep 2019 17:22:39 -0400 T4 - A Pilot Study Assessing the Cognitive Profile in Neuroendocrine Tumour (NET) Patients with Carcinoid Syndrome (CS) https://nanets.net/abstracts-archive/2019/1349-t4-a-pilot-study-assessing-the-cognitive-profile-in-neuroendocrine-tumour-net-patients-with-carcinoid-syndrome-cs?format=html T4 - A Pilot Study Assessing the Cognitive Profile in Neuroendocrine Tumour (NET) Patients with Carcinoid Syndrome (CS) Rachel Goodwin; Horia Marginean; Joanna Gotfrit; Tim Asmis; Michael Vickers; Stewart Longman; Janice Pasieka

Abstract ID: 130

]]> https://nanets.net/abstracts-archive/2019/1349-t4-a-pilot-study-assessing-the-cognitive-profile-in-neuroendocrine-tumour-net-patients-with-carcinoid-syndrome-cs?format=html Rachel Goodwin; Horia Marginean; Joanna Gotfrit; Tim Asmis; Michael Vickers; Stewart Longman; Janice Pasieka

Abstract ID: 130

]]> terryh@adgcommunications.com (Holly Terry) 2019 Thu, 19 Sep 2019 17:22:39 -0400 P20 - Differential Diagnosis (DDX) of Carcinoid Syndrome Diarrhea (CSD): A Systematic Literature Review (SLR) https://nanets.net/abstracts-archive/2019/1345-p20-differential-diagnosis-ddx-of-carcinoid-syndrome-diarrhea-csd-a-systematic-literature-review-slr?format=html P20 - Differential Diagnosis (DDX) of Carcinoid Syndrome Diarrhea (CSD): A Systematic Literature Review (SLR) Mohid Khan; Thomas Walter; Amy Buchanan-Hughes; Lucie Keeber; Marion Feuilly; Enrique Grande

Abstract ID: 114

]]> https://nanets.net/abstracts-archive/2019/1345-p20-differential-diagnosis-ddx-of-carcinoid-syndrome-diarrhea-csd-a-systematic-literature-review-slr?format=html Mohid Khan; Thomas Walter; Amy Buchanan-Hughes; Lucie Keeber; Marion Feuilly; Enrique Grande

Abstract ID: 114

]]> terryh@adgcommunications.com (Holly Terry) 2019 Thu, 19 Sep 2019 17:22:38 -0400 T1 - Randomized Embolization Trial for Neuroendocrine Tumors (RETNET): First Safety Report https://nanets.net/abstracts-archive/2019/1346-t1-randomized-embolization-trial-for-neuroendocrine-tumors-retnet-first-safety-report?format=html T1 - Randomized Embolization Trial for Neuroendocrine Tumors (RETNET): First Safety Report Michael Soulen; Rony Avritscher; Ghassan El-Haddad; Nicholas Fidelman; Ricardo Garcia-Monaco; Sarah White; E. Paul Wileyto

Abstract ID: 15

]]> https://nanets.net/abstracts-archive/2019/1346-t1-randomized-embolization-trial-for-neuroendocrine-tumors-retnet-first-safety-report?format=html Michael Soulen; Rony Avritscher; Ghassan El-Haddad; Nicholas Fidelman; Ricardo Garcia-Monaco; Sarah White; E. Paul Wileyto

Abstract ID: 15

]]> terryh@adgcommunications.com (Holly Terry) 2019 Thu, 19 Sep 2019 17:22:38 -0400 T2 - Analyses of Patient Diaries in the NETTER-1 Study of 177Lu-DOTATATE vs. High Dose OCTREOTIDE in Progressive Midgut Neuroendocrine Tumors https://nanets.net/abstracts-archive/2019/1347-t2-analyses-of-patient-diaries-in-the-netter-1-study-of-177lu-dotatate-vs-high-dose-octreotide-in-progressive-midgut-neuroendocrine-tumors?format=html T2 - Analyses of Patient Diaries in the NETTER-1 Study of 177Lu-DOTATATE vs. High Dose OCTREOTIDE in Progressive Midgut Neuroendocrine Tumors Jonathan Strosberg; Edward Wolin; Beth Chasen; Matthew Kulke; David Bushnell; Caplin Martin; Richard Baum; Timothy Hobday; Andrew Hendifar; Paola Santoro; Per Broberg; Arnaud Demange; Kjell Öberg; Philippe Ruszniewski; Eric Krenning

Abstract ID: 99

]]> https://nanets.net/abstracts-archive/2019/1347-t2-analyses-of-patient-diaries-in-the-netter-1-study-of-177lu-dotatate-vs-high-dose-octreotide-in-progressive-midgut-neuroendocrine-tumors?format=html Jonathan Strosberg; Edward Wolin; Beth Chasen; Matthew Kulke; David Bushnell; Caplin Martin; Richard Baum; Timothy Hobday; Andrew Hendifar; Paola Santoro; Per Broberg; Arnaud Demange; Kjell Öberg; Philippe Ruszniewski; Eric Krenning

Abstract ID: 99

]]> terryh@adgcommunications.com (Holly Terry) 2019 Thu, 19 Sep 2019 17:22:38 -0400 P19 - Symptom Burden at the End of Life for Neuroendocrine Tumors: A Population-Based Analysis of Patient-Reported Outcomes https://nanets.net/abstracts-archive/2019/1344-p19-symptom-burden-at-the-end-of-life-for-neuroendocrine-tumors-a-population-based-analysis-of-patient-reported-outcomes?format=html P19 - Symptom Burden at the End of Life for Neuroendocrine Tumors: A Population-Based Analysis of Patient-Reported Outcomes Julie Hallet; Laura Davis; Alyson Mahar; Calvin Law; Elie Isenberg-Grzeda; Sten Myrehaug; Haoyu Zhao; Kaitlyn Beyfuss; Lesley Moody; Natalie Coburn

Abstract ID: 166

]]> https://nanets.net/abstracts-archive/2019/1344-p19-symptom-burden-at-the-end-of-life-for-neuroendocrine-tumors-a-population-based-analysis-of-patient-reported-outcomes?format=html Julie Hallet; Laura Davis; Alyson Mahar; Calvin Law; Elie Isenberg-Grzeda; Sten Myrehaug; Haoyu Zhao; Kaitlyn Beyfuss; Lesley Moody; Natalie Coburn

Abstract ID: 166

]]> terryh@adgcommunications.com (Holly Terry) 2019 Thu, 19 Sep 2019 17:22:37 -0400 P16 - Renal Neuroendocrine Tumors: Definitive Surgery is the Cornerstone of Longevity https://nanets.net/abstracts-archive/2019/1341-p16-renal-neuroendocrine-tumors-definitive-surgery-is-the-cornerstone-of-longevity?format=html P16 - Renal Neuroendocrine Tumors: Definitive Surgery is the Cornerstone of Longevity Andrew Nguyen; James De Andrade; Christopher Larocca; Camille Stewart; Phillip Ituarte; Jonathan Kessler; Gagandeep Singh; Sue Chang; Daneng Li

Abstract ID: 138

]]> https://nanets.net/abstracts-archive/2019/1341-p16-renal-neuroendocrine-tumors-definitive-surgery-is-the-cornerstone-of-longevity?format=html Andrew Nguyen; James De Andrade; Christopher Larocca; Camille Stewart; Phillip Ituarte; Jonathan Kessler; Gagandeep Singh; Sue Chang; Daneng Li

Abstract ID: 138

]]> terryh@adgcommunications.com (Holly Terry) 2019 Thu, 19 Sep 2019 17:22:36 -0400 P17 - DIPNECH: The Mayo Experience https://nanets.net/abstracts-archive/2019/1342-p17-dipnech-the-mayo-experience?format=html P17 - DIPNECH: The Mayo Experience Daniel Almquist; Arriana Cabrera; Heidi Kosiorek; Mohamad Sonbol; Thorvardur Halfdanarson; Helen Ross; Dawn Jaroszewski; Harshita Paripati

Abstract ID: 141

]]> https://nanets.net/abstracts-archive/2019/1342-p17-dipnech-the-mayo-experience?format=html Daniel Almquist; Arriana Cabrera; Heidi Kosiorek; Mohamad Sonbol; Thorvardur Halfdanarson; Helen Ross; Dawn Jaroszewski; Harshita Paripati

Abstract ID: 141

]]> terryh@adgcommunications.com (Holly Terry) 2019 Thu, 19 Sep 2019 17:22:36 -0400 P18 - Incidence and Survival Patterns of Gastroenteropancreatic Neuroendocrine Neoplasms in California https://nanets.net/abstracts-archive/2019/1343-p18-incidence-and-survival-patterns-of-gastroenteropancreatic-neuroendocrine-neoplasms-in-california?format=html P18 - Incidence and Survival Patterns of Gastroenteropancreatic Neuroendocrine Neoplasms in California Alan Paciorek; Brandon Shih; Meg McKinley; Iona Cheng; Li Zhang; Claire Mulvey; Ann Griffin; Eric Nakakura; Katherine Van Loon; Emily Bergsland

Abstract ID: 161

]]> https://nanets.net/abstracts-archive/2019/1343-p18-incidence-and-survival-patterns-of-gastroenteropancreatic-neuroendocrine-neoplasms-in-california?format=html Alan Paciorek; Brandon Shih; Meg McKinley; Iona Cheng; Li Zhang; Claire Mulvey; Ann Griffin; Eric Nakakura; Katherine Van Loon; Emily Bergsland

Abstract ID: 161

]]> terryh@adgcommunications.com (Holly Terry) 2019 Thu, 19 Sep 2019 17:22:36 -0400 P14 - Survey of Challenges in Access to Diagnostics and Treatment for NET Patients (SCAN) https://nanets.net/abstracts-archive/2019/1339-p14-survey-of-challenges-in-access-to-diagnostics-and-treatment-for-net-patients-scan?format=html P14 - Survey of Challenges in Access to Diagnostics and Treatment for NET Patients (SCAN) Teodora Kolarova; Simone Leyden; Catherine Bouvier; Dirk Van Genechten; Ronald Hollander

Abstract ID: 122

]]> https://nanets.net/abstracts-archive/2019/1339-p14-survey-of-challenges-in-access-to-diagnostics-and-treatment-for-net-patients-scan?format=html Teodora Kolarova; Simone Leyden; Catherine Bouvier; Dirk Van Genechten; Ronald Hollander

Abstract ID: 122

]]> terryh@adgcommunications.com (Holly Terry) 2019 Thu, 19 Sep 2019 17:22:35 -0400 P15 - Health Related Quality of Life (HRQOL) in Neuroendocrine Tumor - A Systematic Review https://nanets.net/abstracts-archive/2019/1340-p15-health-related-quality-of-life-hrqol-in-neuroendocrine-tumor-a-systematic-review?format=html P15 - Health Related Quality of Life (HRQOL) in Neuroendocrine Tumor - A Systematic Review Rohit Gosain; Renuka Iyer

Abstract ID: 132

]]> https://nanets.net/abstracts-archive/2019/1340-p15-health-related-quality-of-life-hrqol-in-neuroendocrine-tumor-a-systematic-review?format=html Rohit Gosain; Renuka Iyer

Abstract ID: 132

]]> terryh@adgcommunications.com (Holly Terry) 2019 Thu, 19 Sep 2019 17:22:35 -0400 P12 - Real-World Comparative Analysis of Lanreotide and Octreotide Long-Acting Release (Lar) Use for Neuroendocrine Tumors (NETs) in Canada https://nanets.net/abstracts-archive/2019/1337-p12-real-world-comparative-analysis-of-lanreotide-and-octreotide-long-acting-release-lar-use-for-neuroendocrine-tumors-nets-in-canada?format=html P12 - Real-World Comparative Analysis of Lanreotide and Octreotide Long-Acting Release (Lar) Use for Neuroendocrine Tumors (NETs) in Canada Jonathan Loree; Marion Feuilly; Callahan Laforty; Anna Liovas; Heather McKechnie; Winson Cheung

Abstract ID: 96

]]> https://nanets.net/abstracts-archive/2019/1337-p12-real-world-comparative-analysis-of-lanreotide-and-octreotide-long-acting-release-lar-use-for-neuroendocrine-tumors-nets-in-canada?format=html Jonathan Loree; Marion Feuilly; Callahan Laforty; Anna Liovas; Heather McKechnie; Winson Cheung

Abstract ID: 96

]]> terryh@adgcommunications.com (Holly Terry) 2019 Thu, 19 Sep 2019 17:22:34 -0400